Potential functions and applications of diverse microbial exopolysaccharides in marine environments

Bioprospecting of exopolysaccharides from the endophytic fungi Epicoccum sorghinum AMFS4, for its structure, composition, bioactivities and application in seed priming

The endophytic fungi, Epicoccum sorghinum AMFS4 was investigated for its metabolic components and composition of bioactive exopolysaccharides (EPS). Metabolic analysis of the ethyl acetate extract majorly detected sugars derivatives such as, 4-Cholesten-3-one semicarbazone (20.9%), d-Fructose (18.96%), and α-d-Galactopyranosiduronicacid (1.71%). The growth curve and EPS yield were determined as 12.22 ± 1.02 g/L and 7.41 ± 0.32 g/L (dry weight) respectively on day 8. The deproteined EPS has been characterised with pyranose ring linked by α-glycosidic bonds, composing fructose, galactose and glucose monosaccharides validated by HPLC. Total sugar content was found to be 93.18 ± 0.81% with detection of proteins and uronate. The viscous EPS appeared filamentous under SEM observation and behaves as emulsifier with notable antioxidant properties. Priming of EPS on tomato seeds showed early induction of secondary rooting than in the control seedlings. Thus, E. sorghinum AMFS4 synthesises bioactive EPS with simple carbohydrate structure, good water absorption and significant metabolic influence on seed germination.

Microbial exopolysaccharides: Unveiling the pharmacological aspects for therapeutic advancements

Microbial exopolysaccharides (EPSs) have emerged as a fascinating area of research in the field of pharmacology due to their diverse and potent biological activities. This review paper aims to provide a comprehensive overview of the pharmacological properties exhibited by EPSs, shedding light on their potential applications in various therapeutic areas. The review begins by introducing EPSs, exploring their various sources, significance in microbial growth and survival, and their applications across different industries. Subsequently, a thorough examination of the pharmaceutical properties of microbial EPSs unveils their antioxidant, immunomodulatory, antimicrobial, antidepressant, antidiabetic, antiviral, antihyperlipidemic, hepatoprotective, anti-inflammatory, and anticancer activities. Mechanistic insights into how different EPSs exert these therapeutic effects have also been discussed in this review. The review also provides comprehensive information about the monosaccharide composition, backbone, branches, glycosidic bonds, and molecular weight of pharmacologically active EPSs from various microbial sources. Furthermore, the factors that can affect the pharmacological activities of EPSs and approaches to improve the EPSs' pharmacological activity have also been discussed. In conclusion, this review illuminates the immense pharmaceutical promise of microbial EPS as versatile bioactive compounds with wide-ranging therapeutic applications. By elucidating their structural features, biological activities, and potential applications, this review aims to catalyze further research and development efforts in leveraging the pharmaceutical potential of microbial EPS for the advancement of human health and well-being, while also contributing to sustainable and environmentally friendly practices in the pharmaceutical industry.

Tapping the biosynthetic potential of marine Bacillus licheniformis LHG166, a prolific sulphated exopolysaccharide producer: structural insights, bio-prospecting its antioxidant, antifungal, antibacterial and anti-biofilm potency as a novel anti-infective lead

The escalating global threat of antimicrobial resistance necessitates prospecting uncharted microbial biodiversity for novel therapeutic leads. This study mines the promising chemical richness of Bacillus licheniformis LHG166, a prolific exopolysaccharide (EPSR2-7.22 g/L). It comprised 5 different monosaccharides with 48.11% uronic acid, 17.40% sulfate groups, and 6.09% N-acetyl glucosamine residues. EPSR2 displayed potent antioxidant activity in DPPH and ABTS+, TAC and FRAP assays. Of all the fungi tested, the yeast Candida albicans displayed the highest susceptibility and antibiofilm inhibition. The fungi Aspergillus niger and Penicillium glabrum showed moderate EPSR2 susceptibility. In contrast, the fungi Mucor circinelloides and Trichoderma harzianum were resistant. Among G+ve tested bacteria, Enterococcus faecalis was the most susceptible, while Salmonella typhi was the most sensitive to G-ve pathogens. Encouragingly, EPSR2 predominantly demonstrated bactericidal effects against both bacterial classes based on MBC/MIC of either 1 or 2 superior Gentamicin. At 75% of MBC, EPSR2 displayed the highest anti-biofilm activity of 88.30% against B. subtilis, while for G-ve antibiofilm inhibition, At 75% of MBC, EPSR2 displayed the highest anti-biofilm activity of 96.63% against Escherichia coli, Even at the lowest dose of 25% MBC, EPSR2 reduced biofilm formation by 84.13% in E. coli, 61.46% in B. subtilis. The microbial metabolite EPSR2 from Bacillus licheniformis LHG166 shows promise as an eco-friendly natural antibiotic alternative for treating infections and oxidative stress.

Exopolysaccharide production by salt-tolerant bacteria: Recent advances, current challenges, and future prospects

Natural biopolymers derived from exopolysaccharides (EPSs) are considered eco-friendly and sustainable alternatives to available traditional synthetic counterparts. Salt-tolerant bacteria inhabiting harsh ecological niches have evolved a number of unique adaptation strategies allowing them to maintain cellular integrity and assuring their long-term survival; among these, producing EPSs can be adopted as an effective strategy to thrive under high-salt conditions. A great diversity of EPSs from salt-tolerant bacteria have attracted widespread attention recently. Because of factors such as their unique structural, physicochemical, and functional characteristics, EPSs are commercially valuable for the global market and their application potential in various sectors is promising. However, large-scale production and industrial development of these biopolymers are hindered by their low yields and high costs. Consequently, the research progress and future prospects of salt-tolerant bacterial EPSs must be systematically reviewed to further promote their application and commercialization. In this review, the structure and properties of EPSs produced by a variety of salt-tolerant bacterial strains isolated from different sources are summarized. Further, feasible strategies for solving production bottlenecks are discussed, which provides a scientific basis and direct reference for more scientific and rational EPS development.

Engineering strategies and applications of cyanobacterial exopolysaccharides: A review on past achievements and recent perspectives

Cyanobacteria are ideally suited for developing sustainable biological products but are underdeveloped due to a lack of genetic tools. Exopolysaccharide (EPS) is one of the essential bioproducts with widespread industrial applications. Despite their unique structural characteristics associated with distinct biological and physicochemical aspects, EPS from cyanobacteria has been underexplored. However, it is expected to accelerate in the near future due to the utilization of low-cost cyanobacterial platforms and readily available information on the structural data and specific features of these biopolymers. In recent years, cyanobacterial EPSs have attracted growing scientific attention due to their simple renewability, rheological characteristics, massive production, and potential uses in several biotechnology domains. This review focuses on the most recent research on potential new EPS producers and their distinct compositions responsible for novel biological activities. Additionally, nutritional and process parameters discovered recently for enhancing EPS production and engineering strategies applied currently to control the biosynthetic pathway for enhanced EPS production are critically highlighted. The process intensification of previously developed EPS extraction and purification processes from cyanobacterial biomass is also extensively explained. Furthermore, the newly reported biotechnological applications of cyanobacterial exopolysaccharides are also discussed.

Heavy metal tolerance, and metal biosorption by exopolysaccharides produced by bacterial strains isolated from marine hydrothermal vents

The present study highlights heavy metal tolerance, EPS production, and biosorption capacity of four hydrothermal vent bacterial strains, namely Exiguobacterium aquaticum, Mammaliicoccus sciuri, Micrococcus luteus, and Jeotgalicoccus huakuii against As, Cd, Cr, Cu, Co, Pb and Ni. The biosorption assay showed high removal efficiency of As (83%) by E. aquaticum, Cd (95%) by M. sciuri, Cu (94%) by M. luteus, and Ni (89%) by J. huakuii and their produced EPS with these metals in aqueous solution were 84%, 85%, 98%, and 91%, respectively. The maximum EPS yield was attained by optimized medium composition consisting of 1% Xylose, and 1% NaCl at pH 7. In metal-amended conditions, the four bacterial strains showed induced EPS production in the initial concentrations. SEM with EDX and CLSM images showed that the growth and EPS production of bacterial strains were affected by metal ion concentrations. A phenol sulphuric acid method and BCA assay were used to identify both the carbohydrate and total protein content of four extracted EPS. A DPPH assay revealed that EPS influences free radical scavenging and has a highly enhanced synergistic effect with its antioxidant activity. FT-IR analysis of four extracted EPS showed the shifting of peaks in the functional groups of EPS before and after adsorption of metal ions. At pH 5 and after 60 min contact time metal removal efficiency and adsorption capacity increased as calculated for As, Cd, Cu, and Ni by four extracted EPS: (86%, 20 mg/g), (74%, 19 mg/g), (94%, 60 mg/g) and (89%, 32 mg/g) and (89%, 16 mg/g), (85%, 16 mg/g), (96%, 22 mg/g) and (91%, 16 mg/g), respectively. The Langmuir compared to the Freundlich model was found to better represent the adsorption by EPS providing maximum adsorption capacities for As (34.65 mg/g), Cd (52.88 mg/g), Cu (24.91 mg/g), and Ni (58.38 mg/g).

Production of exopolysaccharides from Bacillus licheniformis, a thermophilic bacteria from hot spring of Jharkhand

Thermophiles are the microorganisms which thrive under extreme conditions such as high temperature, making them significant for scientific interest. This study provides information based on isolation of thermophilic strain from Surajkund and Ramkund, hot spring of Jharkhand at 50, 60 and 70 °C. Two of the best isolates were used for the extraction of exopolysaccharides. Additionally, the lyophilized product obtained was further analyzed for protein and total sugar estimation. The FTIR analysis revealed the presence of different functional groups such as hydroxyl, C-H stretching, vibration of aliphatic CH2 and glycosidic linkage, thus proving the product obtained from bacteria was an exopolysaccharides The FESEM analysis of exopolysaccharides show varying surface morphology that is from porous to globular structure. Based on 16S rRNA sequences, the isolates from Surajkund (ON795919) and Ramkund (ON795916) were different strains of Bacillus licheniformis. This is the first report on exopolysaccharide secreting thermophilic strain from these hot springs.

Taxonomic identification and temperature stress tolerance mechanisms of Aequorivita marisscotiae sp. nov

The deep sea harbours microorganisms with unique life characteristics and activities due to adaptation to particular environmental conditions, but the limited sample collection and pure culture techniques available constrain the study of deep-sea microorganisms. In this study, strain Ant34-E75 was isolated from Antarctic deep-sea sediment samples and showed the highest 16 S rRNA gene sequence similarity (97.18%) with the strain Aequorivita viscosa 8-1bT. Strain Ant34-E75 is psychrotrophic and can effectively increase the cold tolerance of Chlamydomonas reinhardtii (a model organism). Subsequent transcriptome analysis revealed multiple mechanisms involved in the Ant34-E75 response to temperature stress, and weighted gene co-expression network analysis (WGCNA) showed that the peptidoglycan synthesis pathway was the key component. Overall, this study provides insights into the characteristics of a deep-sea microorganism and elucidates mechanisms of temperature adaptation at the molecular level.

Optimisation, characterization, and biological evaluation of novel exopolysaccharide from Bacillus licheniformis (BITSL006)

The study investigated production, characterisation, and biological properties of exopolysaccharide (EPS) from a thermophilic bacterium, Bacillus licheniformis using sucrose as a main carbon source at a temperature of 75 °C, resulting in a yield of 2.87 g/L. The surface topology of EPS was determined using FESEM indicating its porous nature. Subsequently, FTIR was employed to examine EPS and identified the presence of carboxyl and hydroxyl groups, which are believed to be associated with water-holding capacity (WHC). Comparing the FTIR spectrum of various exopolysaccharides, it was inferred that the exopolysaccharide derived from Ramkund closely resembles dextran. EDX and ICP-MS analysis revealed the presence of Sulphur and Selenium which might be involved in the anticancer properties of EPS. This is the first report on bacterial EPS from a hot spring (Ram kund) with antioxidant property, WHC, and high solubility. These properties offer beneficial resources for exploration in the pharmaceutical and agriculture industries.

Production of Bacterial Exopolysaccharides: Xanthan and Bacterial Cellulose

Recently, degradable biopolymers have become increasingly important as potential environmentally friendly biomaterials, providing a wide range of applications in various fields. Bacterial exopolysaccharides (EPSs) are biomacromolecules, which due to their unique properties have found applications in biomedicine, foodstuff, textiles, cosmetics, petroleum, pharmaceuticals, nanoelectronics, and environmental remediation. One of the important commercial polysaccharides produced on an industrial scale is xanthan. In recent years, the range of its application has expanded significantly. Bacterial cellulose (BC) is another unique EPS with a rapidly increasing range of applications. Due to the great prospects for their practical application, the development of their highly efficient production remains an important task. The present review summarizes the strategies for the cost-effective production of such important biomacromolecules as xanthan and BC and demonstrates for the first time common approaches to their efficient production and to obtaining new functional materials for a wide range of applications, including wound healing, drug delivery, tissue engineering, environmental remediation, nanoelectronics, and 3D bioprinting. In the end, we discuss present limitations of xanthan and BC production and the line of future research.

Microbial exopolysaccharides in the biomedical and pharmaceutical industries

The most significant and renewable class of polymeric materials are extracellular exopolysaccharides (EPSs) produced by microorganisms. Because of their diverse chemical and structural makeup, EPSs play a variety of functions in a variety of industries, including the agricultural industry, dairy industry, biofilms, cosmetics, and others, demonstrating their biotechnological significance. EPSs are typically utilized in high-value applications, and current research has focused heavily on them because of their biocompatibility, biodegradability, and compatibility with both people and the environment. Due to their high production costs, only a few microbial EPSs have been commercially successful. The emergence of financial barriers and the growing significance of microbial EPSs in industrial and medical biotechnology has increased interest in exopolysaccharides. Since exopolysaccharides can be altered in a variety of ways, their use is expected to increase across a wide range of industries in the coming years. This review introduces some significant EPSs and their composites while concentrating on their biomedical uses.

Marine Microbial Polysaccharides: An Untapped Resource for Biotechnological Applications

As the largest habitat on Earth, the marine environment harbors various microorganisms of biotechnological potential. Indeed, microbial compounds, especially polysaccharides from marine species, have been attracting much attention for their applications within the medical, pharmaceutical, food, and other industries, with such interest largely stemming from the extensive structural and functional diversity displayed by these natural polymers. At the same time, the extreme conditions within the aquatic ecosystem (e.g., temperature, pH, salinity) may not only induce microorganisms to develop a unique metabolism but may also increase the likelihood of isolating novel polysaccharides with previously unreported characteristics. However, despite their potential, only a few microbial polysaccharides have actually reached the market, with even fewer being of marine origin. Through a synthesis of relevant literature, this review seeks to provide an overview of marine microbial polysaccharides, including their unique characteristics. In particular, their suitability for specific biotechnological applications and recent progress made will be highlighted before discussing the challenges that currently limit their study as well as their potential for wider applications. It is expected that this review will help to guide future research in the field of microbial polysaccharides, especially those of marine origin.

Microalgae biofilm system as an efficient tool for wastewater remediation and potential bioresources for pharmaceutical product production: an overview

The role of microalgae in wastewater remediation and metabolite production has been well documented, but the limitations of microalgae harvesting and low biomass production call for a more sustainable method of microalgae utilization. The current review gives an insight on how microalgae biofilms can be utilized as a more efficient system for wastewater remediation and as potential source of metabolite for pharmaceutical product production. The review affirms that the extracellular polymeric substance (EPS) is the vital component of the microalgae biofilm because it influences the spatial organization of the organisms forming microalgae biofilm. The EPS is also responsible for the ease interaction between organisms forming microalgae biofilm. This review restate the crucial role play by EPS in the removal of heavy metals from water to be due to the presence of binding sites on its surface. This review also attribute the ability of microalgae biofilm to bio-transform organic pollutant to be dependent on enzymatic activities and the production of reactive oxygen species (ROS). The review assert that during the treatment of wastewater, the wastewater pollutants induce oxidative stress on microalgae biofilms. The response of the microalgae biofilm toward counteracting the stress induced by ROS leads to production of metabolites. These metabolites are important tools that can be harness for the production of pharmaceutical products.

Exopolysaccharides Producing Bacteria: A Review

Bacterial exopolysaccharides (EPS) are essential natural biopolymers used in different areas including biomedicine, food, cosmetic, petroleum, and pharmaceuticals and also in environmental remediation. The interest in them is primarily due to their unique structure and properties such as biocompatibility, biodegradability, higher purity, hydrophilic nature, anti-inflammatory, antioxidant, anti-cancer, antibacterial, and immune-modulating and prebiotic activities. The present review summarizes the current research progress on bacterial EPSs including their properties, biological functions, and promising applications in the various fields of science, industry, medicine, and technology, as well as characteristics and the isolation sources of EPSs-producing bacterial strains. This review provides an overview of the latest advances in the study of such important industrial exopolysaccharides as xanthan, bacterial cellulose, and levan. Finally, current study limitations and future directions are discussed.

Microbial Exopolysaccharide Composites in Biomedicine and Healthcare: Trends and Advances

Microbial exopolysaccharides (EPSs), e.g., xanthan, dextran, gellan, curdlan, etc., have significant applications in several industries (pharma, food, textiles, petroleum, etc.) due to their biocompatibility, nontoxicity, and functional characteristics. However, biodegradability, poor cell adhesion, mineralization, and lower enzyme activity are some other factors that might hinder commercial applications in healthcare practices. Some EPSs lack biological activities that make them prone to degradation in ex vivo, as well as in vivo environments. The blending of EPSs with other natural and synthetic polymers can improve the structural, functional, and physiological characteristics, and make the composites suitable for a diverse range of applications. In comparison to EPS, composites have more mechanical strength, porosity, and stress-bearing capacity, along with a higher cell adhesion rate, and mineralization that is required for tissue engineering. Composites have a better possibility for biomedical and healthcare applications and are used for 2D and 3D scaffold fabrication, drug carrying and delivery, wound healing, tissue regeneration, and engineering. However, the commercialization of these products still needs in-depth research, considering commercial aspects such as stability within ex vivo and in vivo environments, the presence of biological fluids and enzymes, degradation profile, and interaction within living systems. The opportunities and potential applications are diverse, but more elaborative research is needed to address the challenges. In the current article, efforts have been made to summarize the recent advancements in applications of exopolysaccharide composites with natural and synthetic components, with special consideration of pharma and healthcare applications.

Biofilm-based technology for industrial wastewater treatment: current technology, applications and future perspectives

The microbial community in biofilm is safeguarded from the action of toxic chemicals, antimicrobial compounds, and harsh/stressful environmental circumstances. Therefore, biofilm-based technology has nowadays become a successful alternative for treating industrial wastewater as compared to suspended growth-based technologies. In biofilm reactors, microbial cells are attached to static or free-moving materials to form a biofilm which facilitates the process of liquid and solid separation in biofilm-mediated operations. This paper aims to review the state-of-the-art of recent research on bacterial biofilm in industrial wastewater treatment including biofilm fundamentals, possible applications and problems, and factors to regulate biofilm formation. We discussed in detail the treatment efficiencies of fluidized bed biofilm reactor (FBBR), trickling filter reactor (TFR), rotating biological contactor (RBC), membrane biofilm reactor (MBfR), and moving bed biofilm reactor (MBBR) for different types of industrial wastewater treatment. Besides, biofilms have many applications in food and agriculture, biofuel and bioenergy production, power generation, and plastic degradation. Furthermore, key factors for regulating biofilm formation were also emphasized. In conclusion, industrial applications make evident that biofilm-based treatment technology is impactful for pollutant removal. Future research to address and improve the limitations of biofilm-based technology in wastewater treatment is also discussed.